Document headings vary by document type but may contain
                    the following: the agency or agencies that issued and signed a document
the number of the CFR title and the number of each part
                      the document amends, proposes to amend, or is directly
                      related to
the agency docket number / agency internal file number
the RIN which identifies each regulatory action listed in
                      the Unified Agenda of Federal Regulatory and Deregulatory
                      Actions See the
                    Document Drafting Handbook
                    for more details.
 Department of Health and Human Services Centers for Disease Control and Prevention [30Day-22-0978]
 In accordance with the Paperwork Reduction Act of 1995, the Centers for Disease Control and Prevention (CDC) has submitted the information collection request titled “Emerging Infections Program (EIP)” to the Office of Management and Budget (OMB) for review and approval. CDC previously published a “Proposed Data Collection Submitted for Public Comment and Recommendations” notice on January 31, 2022, to obtain comments from the public and affected agencies. CDC did not receive comments related to the previous notice. This notice serves to allow an additional 30 days for public and affected agency comments. CDC will accept all comments for this proposed information collection project. The Office of Management and Budget is particularly interested in comments that: (a) Evaluate whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information will have practical utility; (b) Evaluate the accuracy of the agencies estimate of the burden of the proposed collection of information, including the validity of the methodology and assumptions used; (c) Enhance the quality, utility, and clarity of the information to be collected; (d) Minimize the burden of the collection of information on those who are to respond, including, through the use of appropriate automated, electronic, mechanical, or other technological collection techniques or other forms of information technology, 
                    *e.g.,*
                     permitting electronic submission of responses; and (e) Assess information collection costs. To request additional information on the proposed project or to obtain a copy of the information collection plan and instruments, call (404) 639-7570. Comments and recommendations for the proposed information collection should be sent within 30 days of publication of this notice to 
                    *www.reginfo.gov/​public/​do/​PRAMain.*
                     Find this particular information collection by selecting “Currently under 30-day Review—Open for Public Comments” or by using the search function. Direct written comments and/or suggestions regarding the items contained in this notice to the Attention: CDC Desk Officer, Office of Management and Budget, 725 17th Street NW, Washington, DC 20503 or by fax to (202) 395-5806. Provide written comments within 30 days of notice publication. Proposed Project Emerging Infections Program (OMB Control No. 0920-0978, Exp. 4/30/2022)—Revision—National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Centers for Disease Control and Prevention (CDC). Background and Brief Description The Emerging Infections Programs (EIPs) are population-based centers of excellence established through a network of state health departments collaborating with academic institutions; local health departments; public health and clinical laboratories; infection control professionals; and healthcare providers. EIPs assist in local, state, and national efforts to prevent, control, and monitor the public health impact of infectious diseases. Activities of the EIPs fall into the following general categories: (1) Active surveillance; (2) applied public health epidemiologic and laboratory activities; (3) implementation and evaluation of pilot prevention/intervention projects; and (4) flexible response to public health emergencies. These activities are designed to: (1) Address issues that the EIP network is particularly suited to investigate; (2) maintain sufficient flexibility for emergency response and new problems as they arise; (3) develop and evaluate public health interventions to inform public health policy and treatment guidelines; (4) incorporate training as a key function; and (5) prioritize projects that lead directly to the prevention of disease. A Revision is being submitted to make existing collection instruments clearer and to add several new forms specifically surveying laboratory practices. These forms will allow the EIP to better detect, identify, track changes in laboratory testing methodology, gather information about laboratory utilization in the EIP catchment area to ensure that all cases are being captured, and survey EIP staff to evaluate program quality. Total estimated burden is 61,956 hours. There is no cost to respondents other than their time. Estimated Annualized Burden Hours
Type of respondent
Form name
Number of
                             respondents
Number of
                             responses per 
                             respondent
Average 
                             burden per  
                             response  
                             (in hours)State Health Department
ABCs Case Report Form
10
809
20/60ABCs Invasive Pneumococcal Disease in Children and Adults Case Report Form
10
127
10/60ABCs 
                            *H.influenzae*
                             Neonatal Sepsis Expanded Surveillance Form
10
6
10/60ABCs Severe GAS Infection Supplemental Form
10
136
20/60ABCs Neonatal Infection Expanded Tracking Form
10
37
20/60FoodNet Campylobacter
10
970
21/60FoodNet Cyclospora
10
42
10/60FoodNet Listeria monocytogenes
10
16
20/60FoodNet Salmonella
10
855
21/60FoodNet Shiga toxin producing E. coli
10
290
20/60FoodNet Shigella
10
234
10/60FoodNet Vibrio
10
46
10/60FoodNet Yersinia
10
55
10/60( print page 24306)FoodNet Hemolytic Uremic Syndrome Case Report Form
10
10
1FoodNet Clinical Laboratory Practices and Testing Volume
10
70
20/60FluSurv-NET Influenza Hospitalization Surveillance Network Case Report Form
10
764
25/60FluSurv-NET Influenza Hospitalization Surveillance Project Vaccination Phone Script Consent Form (English)
10
333
5/60FluSurv-NET Influenza Hospitalization Surveillance Project Vaccination Phone Script (Spanish)
10
333
5/60Influenza Hospitalization Surveillance Project Provider Vaccination History Fax Form (Children/Adults)
10
333
5/60FluSurv-NET Laboratory Survey
10
16
10/60HAIC—MuGSI Case Report Form for Carbapenem-resistant Enterobacteriaceae (CRE) and Acinetobacter baumannii (CRAB)
10
500
28/60HAIC—MuGSI Extended-Spectrum Beta-Lactamase-Producing Enterobacteriaceae (ESBL/iEC)
10
4200
25/60HAIC—Invasive Methicillin-resistant Staphylococcus aureus (MRSA) Infection Case Report Form
10
340
28/60HAIC—Invasive Methicillin-sensitive Staphylococcus aureus (MSSA) Infection Case Report Form
10
584
28/60HAIC—CDI Case Report and Treatment Form
10
1650
38/60HAIC Candidemia Case Report
10
200
30/60HAIC—Annual Survey of Laboratory Testing Practices for C. difficile Infections
10
16
19/60HAIC—CDI Annual Surveillance Officers Survey
10
1
15/60HAIC—Emerging Infections Program 
                            *C. difficile*
                             Surveillance Nursing Home Telephone Survey (LTCF)
10
45
5/60HAIC—Invasive Staphylococcus aureus Laboratory Survey
10
11
20/60HAIC—Invasive Staphylococcus aureus Supplemental Surveillance Officers Survey
10
1
10/60HAIC—Laboratory Testing Practices for Candidemia Questionnaire
10
20
12/60HAIC MuGSI CA CP-CRE Health interview (new)
100
10
30/60HAIC MuGSI Supplemental Surveillance Officer Survey (new)
10
1
15/60HAIC Death Ascertainment Variables
10
8
1440/60
 Jeffrey M. Zirger, Lead, Information Collection Review Office, Office of Scientific Integrity, Office of Science, Centers for Disease Control and Prevention.


[FR Doc. 2022-08704 Filed 4-22-22; 8:45 am] BILLING CODE 4163-18-P